Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Gastroenterology. 2010 Jan 4;138(4):1321–1329. doi: 10.1053/j.gastro.2009.12.040

Table 3. Physiological Measures.

Highly Likely Diagnosis of LAS Possible Diagnosis of LAS
Group Baseline 1 Month FU 3 Month FU Baseline 1 Month FU 3 Month FU
Anal Pressure with Straining
(% relaxing)
Biofeedback 13% 94%* 93%* 57%D 81%* 78%*
EGS 10% 52%* B 56%* B 65% D 71% 71%
Massage 10% 29% B 35% B E 90% D 90% D 89% D
Balloon Defecation
(% successful)
Biofeedback 16% 97%* 97%* 62% D 86%* 83%*
EGS 3% 45%* B 48%* B 65% D 71% 71%
Massage 19% 35%* B 42%* B 86% D 90% D 89% D
Resting Anal Canal Pressure
(mmHg)
Biofeedback 69.06±11.45 68.94±11.01 68.17±11.14 67.38±9.52 66.38±10.08 66.42±9.47
EGS 68.03±7.32 67.52±7.25 67.52±7.57 68.90±11.23 66.90±11.12 66.84±10.82
Massage 68.91±12.16 65.10±9.82* 64.31±8.83* 70.90±5.75 68.48±6.23 68.37±6.75
RAIR Threshold
(ml)
Biofeedback 17.10±5.23 16.13±5.58 15.67±5.04* 18.10±6.02 18.10±8.14 15.56±5.11
EGS 16.77±5.99 17.74±5.60 17.04±5.42 15.24±5.12 15.24±5.12 15.26±5.13
Massage 16.56±6.02 16.13±4.95 16.54±4.85 18.57±6.55 18.57±5.73 18.95±6.58
Urge Threshold
(ml)
Biofeedback 64.52±26.44 51.61±8.98* 51.67±9.13* 61.90±21.82 52.38±10.91 52.78±11.79
EGS 62.90±22.24 53.23±12.49* 53.57±13.11* 52.38±10.91 54.76±10.04 55.26±15.17
Massage 56.25±16.80 54.84±15.03 53.85±13.59 52.48±10.91 52.38±10.91 55.00±0.0
Maximum Tolerable Volume
(ml)
Biofeedback 250.00±69.52 229.03±44.30* 226.67±44.98* 247.62±58.04 235.71±57.32 233.33±48.51
EGS 258.06±67.20 238.71±51.17* 240.74±53.77* 240.48±70.03 238.10±65.01 236.84±54.88
Massage 251.56±61.55 250.00±56.27 246.15±58.18 269.05±60.16 259.52±53.90 257.89±53.39
Compliance
(mmHg)
Biofeedback 14.06±3.91 14.68±3.74* 14.57±3.79 15.05±3.67 15.24±3.52 15.11±3.53
EGS 13.77±3.32 13.61±3.20 13.22±3.20 14.05±3.50 14.10±3.39 14.37±3.29
Massage 14.66±4.28 14.52±4.08 14.46±3.63 14.38±2.97 14.29±3.23 14.26±3.00

Data shown are means ± standard deviations.

*

Between times of assessment, different from baseline, p<0.025.

B

Between treatment conditions, different from biofeedback group, p<0.025.

E

Between treatment conditions, different from EGS group, p<0.025.

D

Comparison of highly likely diagnosis to possible diagnosis of LAS, p<0.025.